Articles tagged "Survival"

2021 American Transplant Congress
Living Donor versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-Analysis of Outcomes
A. Barbetta¹, C. Butler², S. Barhouma², R. Hogen¹, B. Roque¹, H. Schillperoort³, G. Meeberg⁴, J. Shapiro⁵, Y. Kwon¹, R. Kohli⁶, J. Emamaullee¹
¹Surgery, abdominal transplat, University of Southern California, Los Angeles, CA, ²University of Southern California, Los Angeles, CA, ³Norris Medical Library, University of Southern California, Los Angeles, CA, ⁴Department of Surgery, University of Alberta, Edmonton, AB, Canada, ⁵Department of Surgery,, University of Alberta, Edmonton, AB, Canada, ⁶Department of Pediatrics, University of Southern California, Los Angeles, CA
*Purpose: Reduced size deceased donors and living donor liver transplantation (LDLT) can help address the organ shortage for pediatric liver transplant candidates. Concerns regarding technical…
2021 American Transplant Congress
A Single Nucleotide Polymorphism within the FCGR3A 158 F/V Gene is Associated with Decreased Survival of Renal Allografts with Chronic Active Antibody-Mediated Rejection
N. H. Litjens, A. M. Peeters, J. A. Kal-van Gestel, M. Klepper, M. G. Betjes
Internal Medicine, Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands
*Purpose: Long-term allograft survival has shown little improvement over the last decades. An important factor compromising long-term allograft survival in kidney transplantation is chronic active…
2021 American Transplant Congress
The Impact of Combined Warm and Cold Ischemia Times on Post Transplant Outcomes
M. E. Foley¹, A. J. Vinson², K. K. Tennankore²
¹Faculty of Medicine, Dalhousie University, Halifax, NS, Canada, ²Division of Nephrology, Medicine, Dalhousie University/ Nova Scotia Health, Halifax, NS, Canada
*Purpose: Both prolonged warm ischemia time (WIT) and cold ischemia time (CIT) have been associated with an increased risk of graft failure following kidney transplantation,…
2021 American Transplant Congress
The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Meld and Exception Statuses
A. Wey¹, S. Noreen², S. Gentry³, N. Salkowski¹, M. Cafarella², R. Hirose⁴, J. Trotter⁵, D. Segev⁶, A. Israni¹, J. Snyder¹, B. Kasiske¹
¹SRTR, Minneapolis, MN, ²UNOS, Richmond, VA, ³USNA, Annapolis, MD, ⁴Univ of San Francisco, San Francisco, CA, ⁵BSW Health, Dallas, TX, ⁶Johns Hopkins, Baltimore, MD
*Purpose: Acuity circles (AC) allocation was implemented on February 4, 2020. AC significantly changed the relative priority of candidates with allocation PELD/MELD scores of 29…
2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
M. G. Naik, K. Sakurayama, K. Budde, F. Halleck
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…
2021 American Transplant Congress
Outcomes After Abo Incompatible Pediatric Liver Transplantation are Comparable to Abo Identical/compatible Transplant
C. Lemoine, K. Brandt, R. Superina
Division of Transplant and Advanced Hepatobiliary Surgery, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: In order to evaluate if the incidence of vascular and biliary complications as well as patient and graft survival in ABO incompatible (ABOi) liver…
2021 American Transplant Congress
Renal Transplant Outcomes of Kidney-only vs. Multi-organ Deceased Donors
J. Espinales¹, Z. C. Giffen¹, D. Schneider², R. James³, N. Koizumi³, O. Ekwenna¹, J. Ortiz⁴
¹University of Toledo Medical Center, Toledo, OH, ²UC Irvine School of Medicine, Irvine, CA, ³George Mason University, Arlington, VA, ⁴Albany Medical Center, Albany, NY
*Purpose: We sought to determine the relative outcomes of kidneys from kidney-only or multi-organ deceased donors.*Methods: Scientific Registry of Transplant Recipients data from 2010-2019 were…
2021 American Transplant Congress
20 Year Survival Following Lung Transplantation
R. M. Reul, Jr¹, S. Barrett¹, A. Alnajar², J. Dunson¹, P. S. Garcha³, G. Loor⁴, J. A. Goss⁴, A. A. Rana⁴
¹Office of Student Affairs, Baylor College of Medicine, Houston, TX, ²Department of Surgery, University of Miami Health System, Miami, FL, ³Department of Medicine, Baylor College of Medicine, Houston, TX, ⁴Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Outcomes following lung transplantation (LTx) have been poor compared to those of heart, liver, and kidney transplants, with 5-year survival rates around 50%. To…
2021 American Transplant Congress
Successful Prophylaxis of Antibody-Mediated Rejection by Downregulation of C5 Expression via RNA Interference in a Rat Kidney Transplant Model
H. Ishigooka¹, S. Motoi², T. Yamakawa¹, C. Matsui², Y. Suzuki³, R. Ishii¹, K. Saiga¹, D. Tokita¹, T. Imai², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²KAN Research Institute, Inc., Kobe, Japan, ³Tsukuba Research Laboratories, Eisai, Co., Ltd., Ibaraki, Japan
*Purpose: Antibody-mediated rejection (AMR) is a major contributor towards poor prognosis in kidney transplantation. Circulating donor-specific antibodies (DSAs) cause AMR with complement activation. This study…
2021 American Transplant Congress
Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:
T. Schachtner, A. Reimann, T. Müller
University Hospital Zurich, Zürich, Switzerland
*Purpose: Despite rapid medical advancements in the field of transplantation over the last decades, long-term kidney allograft survival only slowly improves. Especially little is known…